AHSG and breast carcinoma: Looking at overall survival in breast cancer, tumor cells that produce high levels of Ahsg, as measured by RNAseq, have a poorer survival compared to those that express low levels (Figure 3), with a median survival of 115 months for high expression vs. 148 months for low expression [58].